Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
SynKinase
R788 disodium salt
CHF 0.00
In stock
SYN-1122-M0011 mgCHF 149.00
SYN-1122-M0055 mgCHF 234.00
SYN-1122-M01010 mgCHF 426.00
SYN-1122-M05050 mgCHF 1'376.00
SYN-1122-M100100 mgINQ
Product Details | |
---|---|
Synonyms | Fostamatinib; Tamatinib fosdium; FosD; R-788 |
Product Type | Chemical |
Properties | |
Formula | C23H24FN6O9P . 2Na |
MW | 578.5 . 46.0 |
CAS | 1025687-58-4 |
Purity Chemicals | ≥95% |
Appearance | Solid. |
Solubility | Slightly soluble (<1mg/ml) in DMSO or ethanol. |
Declaration | Manufactured by SynKinase. |
Other Product Data |
Target: BCR | Kinase Group: PTK | Substrate: Tyrosine Click here for Original Manufacturer Product Datasheet Our product description may differ slightly from the original manufacturers product datasheet. |
InChi Key | HSYBQXDGYCYSGA-UHFFFAOYSA-L |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
Tamatinib effectively inhibits BCR signaling in vivo, resulting in reduced proliferation and survival of the malignant B cells and significantly prolonged survival of the treated animals.
Product References
- Rational design of highly selective spleen tyrosine kinase inhibitors: M.C. Lucas, et al.; J. Med. Chem. 55, 10414 (2012)